New Market Research Report : Hyperalgesia – Pipeline Review, H2 2016 has recently announced the addition of a market study “ Hyperalgesia – Pipeline Review, H2 2016 , is a comparative analysis of the global market.

Hyperalgesia – Pipeline Review, H2 2016


Global Markets Directs, Hyperalgesia – Pipeline Review, H2 2016, provides an overview of the Hyperalgesia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperalgesia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hyperalgesia and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Download The sample Copy Of This Report:


– The report provides a snapshot of the global therapeutic landscape of Hyperalgesia

– The report reviews pipeline therapeutics for Hyperalgesia by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Hyperalgesia therapeutics and enlists all their major and minor projects

– The report assesses Hyperalgesia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Hyperalgesia

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of therapeutics under development for Hyperalgesia

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Hyperalgesia pipeline depth and focus of Indication therapeutics

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Hyperalgesia Overview 6

Therapeutics Development 7

Pipeline Products for Hyperalgesia – Overview 7

Pipeline Products for Hyperalgesia – Comparative Analysis 8

Hyperalgesia – Therapeutics under Development by Companies 9

Hyperalgesia – Therapeutics under Investigation by Universities/Institutes 10

Hyperalgesia – Pipeline Products Glance 11

Early Stage Products 11

Hyperalgesia – Products under Development by Companies 12

Hyperalgesia – Products under Investigation by Universities/Institutes 13

Hyperalgesia – Companies Involved in Therapeutics Development 14

Boehringer Ingelheim GmbH 14

Cara Therapeutics, Inc. 15

Shionogi & Co., Ltd. 16

Hyperalgesia – Therapeutics Assessment 17

Assessment by Monotherapy Products 17

Assessment by Target 18

Assessment by Mechanism of Action 20

Assessment by Route of Administration 22

Assessment by Molecule Type 24

Drug Profiles 26

AX-007 – Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

BAM-822 – Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

BI-113823 – Drug Profile 28

Product Description 28

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Read our latest Press Releases at


Mr. Nachiket

State Tower

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA: Canada Toll Free: 866-997-4948



Follow us on LinkedIn: